Spruce Biosciences, Inc. (SPRB)
NASDAQ·Healthcare·Biotechnology
$51.72
+5.33%
Mkt Cap $36.05M
Analyst Ratings
No recent rating data.
Price Target (6 analysts)
$191.00
Range $140.00 – $283.00
Implied Upside
+269.3%
Consensus $191.00 vs current $51.72
NASDAQ·Healthcare·Biotechnology
$51.72
+5.33%
Mkt Cap $36.05M
No recent rating data.
Price Target (6 analysts)
$191.00
Range $140.00 – $283.00
+269.3%
Consensus $191.00 vs current $51.72